Methodological mimesis and the value of pharmaceutical failures
Recent controversies over the safety of drugs such as Vioxx, a painkiller manufactured by Merck, and Seroxat, an SSRI antidepressant manufactured by GlaxoSmithKline, have led to a consequence that at first seems entirely positive: they have attracted more attention to the suppression of negative cli...
Main Author: | McGoey, L |
---|---|
Format: | Conference item |
Published: |
2009
|
Similar Items
-
Pharmaceutical Controversies and the Performative Value of Uncertainty
by: McGoey, L
Published: (2009) -
Pharmaceutical Hope
by: McGoey, L
Published: (2007) -
Through mimesis and methodology
by: Pedroza, Edgar
Published: (2009) -
Profitable failure: antidepressant drugs and the triumph of flawed experiments
by: McGoey, L
Published: (2010) -
Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
by: McGoey, L, et al.
Published: (2008)